TY - JOUR AU - Jemal, A. AU - Siegel, R. AU - Ward, E. AU - Hao, Y. AU - Xu, J. AU - Murray, T. PY - 2008 DA - 2008// TI - Cancer statistics, 2008 JO - CA Cancer J Clin VL - 58 UR - https://doi.org/10.3322/CA.2007.0010 DO - 10.3322/CA.2007.0010 ID - Jemal2008 ER - TY - JOUR AU - Barinaga, M. PY - 1997 DA - 1997// TI - From bench top to bedside JO - Science VL - 278 UR - https://doi.org/10.1126/science.278.5340.1036 DO - 10.1126/science.278.5340.1036 ID - Barinaga1997 ER - TY - JOUR AU - Natoli, C. AU - Perrucci, B. AU - Perrotti, F. AU - Falchi, L. AU - Iacobelli, S. PY - 2010 DA - 2010// TI - Tyrosine kinase inhibitors JO - Curr Cancer Drug Targets VL - 10 UR - https://doi.org/10.2174/156800910791517208 DO - 10.2174/156800910791517208 ID - Natoli2010 ER - TY - JOUR AU - Martin, P. AU - Oliver, S. AU - Kennedy, S. J. AU - Partridge, E. AU - Hutchison, M. AU - Clarke, D. PY - 2012 DA - 2012// TI - Pharmacokinetics of vandetanib: three phase I studies in healthy subjects JO - Clin Ther VL - 34 UR - https://doi.org/10.1016/j.clinthera.2011.11.011 DO - 10.1016/j.clinthera.2011.11.011 ID - Martin2012 ER - TY - JOUR AU - Li, F. AU - Jiang, S. AU - Zu, Y. AU - Lee, D. Y. AU - Li, Z. PY - 2014 DA - 2014// TI - A tyrosine kinase inhibitor-based high-affinity PET radiopharmaceutical targets vascular endothelial growth factor receptor JO - J Nucl Med VL - 55 UR - https://doi.org/10.2967/jnumed.114.138925 DO - 10.2967/jnumed.114.138925 ID - Li2014 ER - TY - JOUR AU - Thornton, K. AU - Kim, G. AU - Maher, V. E. AU - Chattopadhyay, S. AU - Tang, S. AU - Moon, Y. J. PY - 2012 DA - 2012// TI - Vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease: US Food and Drug Administration drug approval summary JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-0411 DO - 10.1158/1078-0432.CCR-12-0411 ID - Thornton2012 ER - TY - JOUR AU - Bai, F. AU - Johnson, J. AU - Wang, F. AU - Yang, L. AU - Broniscer, A. AU - Stewart, C. F. PY - 2011 DA - 2011// TI - Determination of vandetanib in human plasma and cerebrospinal fluid by liquid chromatography electrospray ionization tandem mass spectrometry (LC–ESI–MS/MS) JO - J Chromatogr B Anal Technol Biomed Life Sci VL - 879 UR - https://doi.org/10.1016/j.jchromb.2011.07.012 DO - 10.1016/j.jchromb.2011.07.012 ID - Bai2011 ER - TY - JOUR AU - Lin, H. AU - Cui, D. AU - Cao, Z. AU - Bu, Q. AU - Xu, Y. AU - Zhao, Y. PY - 2014 DA - 2014// TI - Validation of a high-performance liquid chromatographic ultraviolet detection method for the quantification of vandetanib in rat plasma and its application to pharmacokinetic studies JO - J Cancer Res Ther VL - 10 UR - https://doi.org/10.4103/0973-1482.131393 DO - 10.4103/0973-1482.131393 ID - Lin2014 ER - TY - JOUR AU - Darwish, H. W. AU - Bakheit, A. H. PY - 2016 DA - 2016// TI - A new spectrofluorimetric assay method for vandetanib in tablets, plasma and urine JO - Trop J Pharm Res VL - 15 UR - https://doi.org/10.4314/tjpr.v15i10.21 DO - 10.4314/tjpr.v15i10.21 ID - Darwish2016 ER - TY - JOUR AU - Baranczewski, P. AU - Stanczak, A. AU - Sundberg, K. AU - Svensson, R. AU - Wallin, A. AU - Jansson, J. PY - 2006 DA - 2006// TI - Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development JO - Pharmacol rep PR VL - 58 ID - Baranczewski2006 ER - TY - JOUR AU - Jagow, R. AU - Kampffmeyer, H. AU - Kiese, M. PY - 1965 DA - 1965// TI - The preparation of microsomes JO - Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie VL - 251 UR - https://doi.org/10.1007/BF00245731 DO - 10.1007/BF00245731 ID - Jagow1965 ER - TY - JOUR AU - Lowry, O. H. AU - Rosebrough, N. J. AU - Farr, A. L. AU - Randall, R. J. PY - 1951 DA - 1951// TI - Protein measurement with the Folin phenol reagent JO - J Biol Chem VL - 193 ID - Lowry1951 ER - TY - STD TI - Guideline IHT (2005) Validation of analytical procedures: text and methodology. Q2 (R1). 2005;1 ID - ref13 ER - TY - JOUR AU - Fda, A. P. PY - 2000 DA - 2000// TI - Methods validation: chemistry, manufacturing and controls documentation availability JO - Federal Regist (Notices) VL - 65 ID - Fda2000 ER - TY - BOOK AU - Caldwell, G. AU - Yan, Z. PY - 2014 DA - 2014// TI - Optimization in drug discovery: in vitro methods PB - Business Media CY - New York UR - https://doi.org/10.1007/978-1-62703-742-6 DO - 10.1007/978-1-62703-742-6 ID - Caldwell2014 ER - TY - JOUR AU - Kadi, A. A. AU - Darwish, H. W. AU - Attwa, M. W. AU - Amer, S. M. PY - 2016 DA - 2016// TI - Validated LC–MS/MS method for the quantification of ponatinib in plasma: application to metabolic stability JO - PLoS ONE VL - 11 UR - https://doi.org/10.1371/journal.pone.0164967 DO - 10.1371/journal.pone.0164967 ID - Kadi2016 ER -